Literature DB >> 14555612

The role of p53 in base excision repair following genotoxic stress.

Irit Zurer1, Lorne J Hofseth, Yehudit Cohen, Meng Xu-Welliver, S Perwez Hussain, Curtis C Harris, Varda Rotter.   

Abstract

The p53 tumor suppressor protein is involved in apoptosis and cell cycle checkpoints. We have shown recently that p53 also facilitates base excision repair (BER). To further examine p53 involvement in the regulation of BER we chose to focus on 3-methyladenine DNA glycosylase (3-MeAde DNA glycosylase), the first enzyme acting in the BER pathway. 3-MeAde DNA glycosylase activity was found to be modulated by the p53 protein. This modulation was dependent on the type of genotoxic stress used. Gamma-irradiation damage resulted in activation of glycosylase, which was enhanced by p53. Doxorubicin and hydrogen peroxide (H2O2) treatment, although inducing p53 stabilization, did not cause the activation of glycosylase. Nitric oxide (NO) resulted in activation of 3-MeAde DNA glycosylase. Surprisingly this activation was down regulated by wild-type p53. The down regulation of 3-MeAde DNA glycosylase activity was due to trans repression of glycosylase mRNA by p53. Furthermore, we found that AP endonuclease (APE) activity was not altered by NO. Our study provides evidence for a possible antimutagenic role for p53 following exposure of cells to NO species. In the absence of p53, NO exposure results in elevation of 3-MeAde DNA glycosylase activity that results in elevation in the number of AP sites in DNA. At the same time, APE activity does not rise and removal of the AP sites is not further processed resulting in a mutator phenotype. When p53 is present, it down regulates the transcription of 3-MeAde DNA glycosylase. This provides a new model by which p53 prevents the creation of a mutator phenotype.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14555612     DOI: 10.1093/carcin/bgg186

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  18 in total

Review 1.  APE1/Ref-1 role in redox signaling: translational applications of targeting the redox function of the DNA repair/redox protein APE1/Ref-1.

Authors:  Mark R Kelley; Millie M Georgiadis; Melissa L Fishel
Journal:  Curr Mol Pharmacol       Date:  2012-01       Impact factor: 3.339

2.  The antioxidant function of the p53 tumor suppressor.

Authors:  Anna A Sablina; Andrei V Budanov; Galina V Ilyinskaya; Larissa S Agapova; Julia E Kravchenko; Peter M Chumakov
Journal:  Nat Med       Date:  2005-11-13       Impact factor: 53.440

Review 3.  Oncogenic Mutant p53 Gain of Function Nourishes the Vicious Cycle of Tumor Development and Cancer Stem-Cell Formation.

Authors:  Yoav Shetzer; Alina Molchadsky; Varda Rotter
Journal:  Cold Spring Harb Perspect Med       Date:  2016-10-03       Impact factor: 6.915

4.  MTA1 coregulator regulates p53 stability and function.

Authors:  Da-Qiang Li; Sirigiri Divijendra Natha Reddy; Suresh B Pakala; Xifeng Wu; Yanping Zhang; Suresh K Rayala; Rakesh Kumar
Journal:  J Biol Chem       Date:  2009-10-16       Impact factor: 5.157

Review 5.  Targeting the ubiquitin-mediated proteasome degradation of p53 for cancer therapy.

Authors:  Tiffany Devine; Mu-Shui Dai
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

Review 6.  Redox regulation of DNA repair: implications for human health and cancer therapeutic development.

Authors:  Meihua Luo; Hongzhen He; Mark R Kelley; Millie M Georgiadis
Journal:  Antioxid Redox Signal       Date:  2010-06-01       Impact factor: 8.401

7.  The adaptive imbalance in base excision-repair enzymes generates microsatellite instability in chronic inflammation.

Authors:  Lorne J Hofseth; Mohammed A Khan; Mark Ambrose; Olga Nikolayeva; Meng Xu-Welliver; Maria Kartalou; S Perwez Hussain; Richard B Roth; Xiaoling Zhou; Leah E Mechanic; Irit Zurer; Varda Rotter; Leona D Samson; Curtis C Harris
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

Review 8.  Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?

Authors:  Dunyaporn Trachootham; Jerome Alexandre; Peng Huang
Journal:  Nat Rev Drug Discov       Date:  2009-05-29       Impact factor: 84.694

Review 9.  Involvement of p53 in the repair of DNA double strand breaks: multifaceted Roles of p53 in homologous recombination repair (HRR) and non-homologous end joining (NHEJ).

Authors:  Vijay Menon; Lawrence Povirk
Journal:  Subcell Biochem       Date:  2014

10.  HSP90 inhibitor, DMAG, synergizes with radiation of lung cancer cells by interfering with base excision and ATM-mediated DNA repair.

Authors:  Thuy T Koll; Steven S Feis; Mollie H Wright; Modupe M Teniola; Mekel M Richardson; Ana I Robles; John Bradsher; Jacek Capala; Lyuba Varticovski
Journal:  Mol Cancer Ther       Date:  2008-07       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.